Novai Company
Novai is a disruptive British biotech start-up with an AI supported retinal biomarker for use in glaucoma and AMD clinical trials.
Last Funding Type:
Seed
Funding Status:
Seed
Headquarters:
Reading, Reading, United Kingdom
Founded Date:
2020-02-12
Last Funding Date:
2023-01-24
Total Funding:
5328528
Employee Number:
11-50
Investors Number:
2
Industry:
Aging Biomarkers